Cargando…

Bacterial Infections Associated with Immunosuppressive Agents Commonly Used in Patients with Interstitial Lung Diseases

There are about 200 different types of interstitial lung disease (ILD), and a crucial initial step in the assessment of a patient with suspected ILD is achieving an appropriate diagnosis. Some ILDs respond to immunosuppressive agents, while immunosuppression can be detrimental in others, hence treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chaaban, Said, Sadikot, Ruxana T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053664/ https://www.ncbi.nlm.nih.gov/pubmed/36986386 http://dx.doi.org/10.3390/pathogens12030464

Ejemplares similares

Bacterial Pathogens Causing Pneumonia Post Hematopoietic Stem Cell Transplant: The Chronic GVHD Population
por: Chaaban, Said, et al.
Publicado: (2023)

Mitochondrial Dysfunction in Bacterial Infections
por: Maurice, Nicholas M., et al.
Publicado: (2023)

Peptide Nanomedicines for Treatment of Acute Lung Injury
por: Sadikot, Ruxana T.
Publicado: (2012)

Nanomedicine for Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome
por: Sadikot, Ruxana T., et al.
Publicado: (2017)

PGD Synthase and PGD(2) in Immune Resposne
por: Joo, Myungsoo, et al.
Publicado: (2012)

Alternative and Natural Therapies for Acute Lung Injury and Acute Respiratory Distress Syndrome
por: Patel, Vipul J., et al.
Publicado: (2018)

Mesenchymal Stem Cell-Based Therapy of Inflammatory Lung Diseases: Current Understanding and Future Perspectives
por: Harrell, C. Randall, et al.
Publicado: (2019)

Prevalence of latent tuberculosis infection among patients with interstitial lung disease requiring immunosuppression
por: Dias, Vitor Loureiro, et al.
Publicado: (2022)

Prevalence of latent tuberculosis infection among patients with interstitial lung disease requiring immunosuppression
por: Kempisty, Anna, et al.
Publicado: (2022)

TREM-1 Is Induced in Tumor Associated Macrophages by Cyclo-Oxygenase Pathway in Human Non-Small Cell Lung Cancer
por: Yuan, Zhihong, et al.
Publicado: (2014)

Successful treatment of telomeropathy‐related interstitial lung disease with immunosuppression and danazol
por: Chambers, Daniel C., et al.
Publicado: (2020)

Idiopathic pulmonary artery dissection: a case report
por: Mohammad, Khalid, et al.
Publicado: (2009)

Interstitial Lung Disease in Common Variable Immunodeficiency
por: Lopes, Joao Pedro, et al.
Publicado: (2021)

Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease
por: Zhang, David, et al.
Publicado: (2023)

Antisynthetase Syndrome-Associated Interstitial Lung Disease: Monitoring of Immunosuppressive Treatment Effects by Chest Computed Tomography
por: Korsten, Peter, et al.
Publicado: (2021)

Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group
por: Adler, Sabine, et al.
Publicado: (2018)

Interstitial Lung Disease with ANCA-associated Vasculitis
por: Katsumata, Yasuhiro, et al.
Publicado: (2015)

Rheumatoid arthritis-associated interstitial lung disease
por: Solomon, Joshua J, et al.
Publicado: (2012)

Management of Myositis-Associated Interstitial Lung Disease
por: Fujisawa, Tomoyuki
Publicado: (2021)

“Management of myositis associated interstitial lung disease”
por: Thong, Lorraine, et al.
Publicado: (2023)

The Role of Lipids Mediators in Inflammation and Resolution
por: Rogerio, Alexandre de Paula, et al.
Publicado: (2015)

Nontuberculous Mycobacteria: Epidemiologic, Mycobacteriologic, and Clinical Aspects
por: Mirsaeidi, Mehdi, et al.
Publicado: (2015)

Lung transplantation for interstitial lung disease
por: Kapnadak, Siddhartha G., et al.
Publicado: (2021)

Interstitial Lung Disease
Publicado: (1982)

Virtual communication is commonly used in Finnish interstitial lung disease multidisciplinary meetings
por: Salonen, Johanna, et al.
Publicado: (2023)

Histology of Interstitial Lung Disease in Common Variable Immune Deficiency
por: Dhalla, Fatima, et al.
Publicado: (2020)

Granulomatous lymphocytic interstitial lung disease: limiting immunosuppressive therapy—a single‐centre experience
por: Beaton, Thomas J., et al.
Publicado: (2020)

Protecting the vulnerable: SARS-CoV-2 vaccination in immunosuppressed patients with interstitial lung disease
por: Mackintosh, John A, et al.
Publicado: (2021)

ZKSCAN3 in severe bacterial lung infection and sepsis-induced immunosuppression
por: Ouyang, Xiaosen, et al.
Publicado: (2021)

Interstitial lung diseases in children
por: Clement, Annick, et al.
Publicado: (2010)

Telomeres in Interstitial Lung Disease
por: Stock, Carmel J. W., et al.
Publicado: (2021)

Smoking and interstitial lung diseases
por: Margaritopoulos, George A., et al.
Publicado: (2015)

Comorbidities in interstitial lung diseases
por: Margaritopoulos, George A., et al.
Publicado: (2017)

The genetics of interstitial lung diseases
por: Borie, Raphael, et al.
Publicado: (2019)

Immunosuppressive Mechanisms in Brucellosis in Light of Chronic Bacterial Diseases
por: Pellegrini, Joaquin Miguel, et al.
Publicado: (2022)

Interstitial lung disease
por: Antoniou, Katerina M., et al.
Publicado: (2014)

Macrophages exposed to HIV viral protein disrupt lung epithelial cell integrity and mitochondrial bioenergetics via exosomal microRNA shuttling
por: Yuan, Zhihong, et al.
Publicado: (2019)

Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 5. Connective Tissue Disease Associated Interstitial Lung Disease
por: Koo, So-My, et al.
Publicado: (2019)

New immunosuppressive agents in pediatric transplantation
por: Nguyen, Christina, et al.
Publicado: (2014)

Post-COVID lung disease(s)
por: Achkar, Michel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ldci1384kvvhpmcf11h8jt0bkt